Corrigendum to “RNA-binding protein HuD reduces triglyceride production in pancreatic β cells by enhancing the expression of insulin-induced gene 1” [Biochim. Biophys. Acta Gene Regul. Mech. 1859/4 (2016) Page 675–685] (Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2016) 1859(4) (675–685), (S1874939916300396), (10.1016/j.bbagrm.2016.02.017));RNA-binding protein HuD reduces triglyceride production in pancreatic β cells by enhancing the expression of insulin-induced gene 1

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1859, Issue 4, 2016, Pages 675-685

  Kim, Chongtae ^a   Lee, Heejin ^a   Kang, Hoin ^a   Shin, Jung Jae ^b   Tak, Hyosun ^a   Kim, Wook ^b   Gorospe, Myriam ^c   Lee, Eun Kyung ^a  

^a The Catholic University of Korea   (South Korea)

^b Ajou University   (South Korea)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

HuD; INSIG1; RNA binding protein; SREBP1c; Triglyceride

Indexed keywords

ELAV LIKE PROTEIN 4; SHORT HAIRPIN RNA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; ELAVL4 PROTEIN, MOUSE; INSIG1 PROTEIN, HUMAN; INSULIN; MEMBRANE PROTEIN; RNA BINDING PROTEIN; SIGNAL PEPTIDE; SREBF1 PROTEIN, MOUSE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FRACTIONATION; GENE; GENE EXPRESSION; IMMUNOPRECIPITATION; INSIG1 GENE; LIPID STORAGE; MOUSE; NONHUMAN; PANCREAS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSCRIPTION REGULATION; WESTERN BLOTTING; ANIMAL; GENETICS; HUMAN; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY;

ANIMALS; DIABETES MELLITUS, TYPE 2; ELAV-LIKE PROTEIN 4; HUMANS; INSULIN; INSULIN-SECRETING CELLS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE; RNA-BINDING PROTEINS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIGLYCERIDES;

EID: 84960919665     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2021.194692     Document Type: Erratum

References (62)

1. Paolisso G., Tataranni P.A., Foley J.E., Bogardus C., Howard B.V., Ravussin E. A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia 1995, 38:1213-1217.
2. Listenberger L.L., Han X., Lewis S.E., Cases S., Farese R.V., Ory D.S., Schaffer J.E. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:3077-3082.
3. Prentki M., Vischer S., Glennon M.C., Regazzi R., Deeney J.T., Corkey B.E. Malonyl-CoA and long chain acyl-CoA esters as metabolic coupling factors in nutrient-induced insulin secretion. J. Biol. Chem. 1992, 267:5802-5810.
4. Zhou Y.P., Grill V. Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans. J. Clin. Endocrinol. Metab. 1995, 80:1584-1590.
5. Shimabukuro M., Zhou Y.T., Levi M., Unger R.H. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:2498-2502.
6. Tushuizen M.E., Bunck M.C., Pouwels P.J., Bontemps S., van Waesberghe J.H., Schindhelm R.K., Mari A., Heine R.J., Diamant M. Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes Care 2007, 30:2916-2921.
7. Sakai J., Duncan E.A., Rawson R.B., Hua X., Brown M.S., Goldstein J.L. Sterol-regulated release of SREBP-2 from cell membranes requires two sequential cleavages, one within a transmembrane segment. Cell 1996, 85:1037-1046.
8. Briggs M.R., Yokoyama C., Wang X., Brown M.S., Goldstein J.L. Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. I. Identification of the protein and delineation of its target nucleotide sequence. J. Biol. Chem. 1993, 268:14490-14496.
9. Wang X., Sato R., Brown M.S., Hua X., Goldstein J.L. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell 1994, 77:53-62.
10. Kim J.B., Sarraf P., Wright M., Yao K.M., Mueller E., Solanes G., Lowell B.B., Spiegelman B.M. Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. J. Clin. Invest. 1998, 101:1-9.
11. Foretz M., Guichard C., Ferre P., Foufelle F. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:12737-12742.
12. Wang H., Maechler P., Antinozzi P.A., Herrero L., Hagenfeldt-Johansson K.A., Bjorklund A., Wollheim C.B. The transcription factor SREBP-1c is instrumental in the development of beta-cell dysfunction. J. Biol. Chem. 2003, 278:16622-16629.
13. Takahashi A., Motomura K., Kato T., Yoshikawa T., Nakagawa Y., Yahagi N., Sone H., Suzuki H., Toyoshima H., Yamada N., Shimano H. Transgenic mice overexpressing nuclear SREBP-1c in pancreatic beta-cells. Diabetes 2005, 54:492-499.
14. Li J., Liu X., Ran X., Chen J., Li X., Wu W., Huang H., Huang H., Long Y., Liang J., Cheng J., Tian H. Sterol regulatory element-binding protein-1c knockdown protected INS-1E cells from lipotoxicity. Diabetes Obes. Metab. 2010, 12:35-46.
15. Yang T., Espenshade P.J., Wright M.E., Yabe D., Gong Y., Aebersold R., Goldstein J.L., Brown M.S. Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell 2002, 110:489-500.
16. Chen K., Jin P., He H.H., Xie Y.H., Xie X.Y., Mo Z.H. Overexpression of Insig-1 protects beta cell against glucolipotoxicity via SREBP-1c. J. Biomed. Sci. 2011, 18:57.
17. Moore M.J. From birth to death: the complex lives of eukaryotic mRNAs. Science 2005, 309:1514-1518.
18. Morris A.R., Mukherjee N., Keene J.D. Systematic analysis of posttranscriptional gene expression. Wiley Interdiscip. Rev. Syst. Biol. Med. 2010, 2:162-180.
19. Fabian M.R., Sonenberg N., Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 2010, 79:351-379.
20. Lunde B.M., Moore C., Varani G. RNA-binding proteins: modular design for efficient function. Nat. Rev. Mol. Cell Biol. 2007, 8:479-490.
21. Good P.J. A conserved family of elav-like genes in vertebrates. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:4557-4561.
22. Akamatsu W., Fujihara H., Mitsuhashi T., Yano M., Shibata S., Hayakawa Y., Okano H.J., Sakakibara S., Takano H., Takano T., Takahashi T., Noda T., Okano H. The RNA-binding protein HuD regulates neuronal cell identity and maturation. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:4625-4630.
23. Anderson K.D., Sengupta J., Morin M., Neve R.L., Valenzuela C.F., Perrone-Bizzozero N.I. Overexpression of HuD accelerates neurite outgrowth and increases GAP-43 mRNA expression in cortical neurons and retinoic acid-induced embryonic stem cells in vitro. Exp. Neurol. 2001, 168:250-258.
24. Kasashima K., Terashima K., Yamamoto K., Sakashita E., Sakamoto H. Cytoplasmic localization is required for the mammalian ELAV-like protein HuD to induce neuronal differentiation. Genes Cells 1999, 4:667-683.
25. Mobarak C.D., Anderson K.D., Morin M., Beckel-Mitchener A., Rogers S.L., Furneaux H., King P., Perrone-Bizzozero N.I. The RNA-binding protein HuD is required for GAP-43 mRNA stability, GAP-43 gene expression, and PKC-dependent neurite outgrowth in PC12 cells. Mol. Biol. Cell 2000, 11:3191-3203.
26. Perrone-Bizzozero N., Bolognani F. Role of HuD and other RNA-binding proteins in neural development and plasticity. J. Neurosci. Res. 2002, 68:121-126.
27. Lee E.K., Kim W., Tominaga K., Martindale J.L., Yang X., Subaran S.S., Carlson O.D., Mercken E.M., Kulkarni R.N., Akamatsu W., Okano H., Perrone-Bizzozero N.I., de Cabo R., Egan J.M., Gorospe M. RNA-binding protein HuD controls insulin translation. Mol. Cell 2012, 45:826-835.
28. Kim C., Kim W., Lee H., Ji E., Choe Y.J., Martindale J.L., Akamatsu W., Okano H., Kim H.S., Nam S.W., Gorospe M., Lee E.K. The RNA-binding protein HuD regulates autophagosome formation in pancreatic beta cells by promoting autophagy-related gene 5 expression. J. Biol. Chem. 2014, 289:112-121.
29. Schwartz E.A., Zhang W.Y., Karnik S.K., Borwege S., Anand V.R., Laine P.S., Su Y., Reaven P.D. Nutrient modification of the innate immune response: a novel mechanism by which saturated fatty acids greatly amplify monocyte inflammation. Arterioscler. Thromb. Vasc. Biol. 2010, 30:802-808.
30. Lal A., Mazan-Mamczarz K., Kawai T., Yang X., Martindale J.L., Gorospe M. Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. EMBO J. 2004, 23:3092-3102.
31. Lee E.K., Kim H.H., Kuwano Y., Abdelmohsen K., Srikantan S., Subaran S.S., Gleichmann M., Mughal M.R., Martindale J.L., Yang X., Worley P.F., Mattson M.P., Gorospe M. hnRNP C promotes APP translation by competing with FMRP for APP mRNA recruitment to P bodies. Nat. Struct. Mol. Biol. 2010, 17:732-739.
32. Diraison F., Ravier M.A., Richards S.K., Smith R.M., Shimano H., Rutter G.A. SREBP1 is required for the induction by glucose of pancreatic beta-cell genes involved in glucose sensing. J. Lipid Res. 2008, 49:814-822.
33. Amemiya-Kudo M., Shimano H., Hasty A.H., Yahagi N., Yoshikawa T., Matsuzaka T., Okazaki H., Tamura Y., Iizuka Y., Ohashi K., Osuga J., Harada K., Gotoda T., Sato R., Kimura S., Ishibashi S., Yamada N. Transcriptional activities of nuclear SREBP-1a, -1c, and -2 to different target promoters of lipogenic and cholesterogenic genes. J. Lipid Res. 2002, 43:1220-1235.
34. Pai J.T., Guryev O., Brown M.S., Goldstein J.L. Differential stimulation of cholesterol and unsaturated fatty acid biosynthesis in cells expressing individual nuclear sterol regulatory element-binding proteins. J. Biol. Chem. 1998, 273:26138-26148.
35. Brown M.S., Goldstein J.L. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:11041-11048.
36. Tanabe K., Liu Y., Hasan S.D., Martinez S.C., Cras-Meneur C., Welling C.M., Bernal-Mizrachi E., Tanizawa Y., Rhodes C.J., Zmuda E., Hai T., Abumrad N.A., Permutt M.A. Glucose and fatty acids synergize to promote B-cell apoptosis through activation of glycogen synthase kinase 3beta independent of JNK activation. PLoS One 2011, 6.
37. Kato T., Shimano H., Yamamoto T., Ishikawa M., Kumadaki S., Matsuzaka T., Nakagawa Y., Yahagi N., Nakakuki M., Hasty A.H., Takeuchi Y., Kobayashi K., Takahashi A., Yatoh S., Suzuki H., Sone H., Yamada N. Palmitate impairs and eicosapentaenoate restores insulin secretion through regulation of SREBP-1c in pancreatic islets. Diabetes 2008, 57:2382-2392.
38. Lee Y., Hirose H., Ohneda M., Johnson J.H., McGarry J.D., Unger R.H. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:10878-10882.
39. Lee Y., Wang M.Y., Kakuma T., Wang Z.W., Babcock E., McCorkle K., Higa M., Zhou Y.T., Unger R.H. Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia. J. Biol. Chem. 2001, 276:5629-5635.
40. Wang M.Y., Grayburn P., Chen S., Ravazzola M., Orci L., Unger R.H. Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:6139-6144.
41. Lingvay I., Esser V., Legendre J.L., Price A.L., Wertz K.M., Adams-Huet B., Zhang S., Unger R.H., Szczepaniak L.S. Noninvasive quantification of pancreatic fat in humans. J. Clin. Endocrinol. Metab. 2009, 94:4070-4076.
42. Lee Y., Lingvay I., Szczepaniak L.S., Ravazzola M., Orci L., Unger R.H. Pancreatic steatosis: harbinger of type 2 diabetes in obese rodents. Int. J. Obes. 2010, 34:396-400.
43. Dong X.Y., Tang S.Q. Insulin-induced gene: a new regulator in lipid metabolism. Peptides 2010, 31:2145-2150.
44. Sun L.P., Seemann J., Goldstein J.L., Brown M.S. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: Insig renders sorting signal in Scap inaccessible to COPII proteins. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:6519-6526.
45. Jeon T.I., Osborne T.F. SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol. Metab. 2012, 23:65-72.
46. Yabe D., Xia Z.P., Adams C.M., Rawson R.B. Three mutations in sterol-sensing domain of SCAP block interaction with insig and render SREBP cleavage insensitive to sterols. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:16672-16677.
47. Janowski B.A. The hypocholesterolemic agent LY295427 upregulates INSIG-1, identifying the INSIG-1 protein as a mediator of cholesterol homeostasis through SREBP. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:12675-12680.
48. Lee J.N., Gong Y., Zhang X., Ye J. Proteasomal degradation of ubiquitinated Insig proteins is determined by serine residues flanking ubiquitinated lysines. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:4958-4963.
49. Gong Y., Lee J.N., Lee P.C., Goldstein J.L., Brown M.S., Ye J. Sterol-regulated ubiquitination and degradation of Insig-1 creates a convergent mechanism for feedback control of cholesterol synthesis and uptake. Cell Metab. 2006, 3:15-24.
50. Keeton A.B., Bortoff K.D., Franklin J.L., Messina J.L. Blockade of rapid versus prolonged extracellularly regulated kinase 1/2 activation has differential effects on insulin-induced gene expression. Endocrinology 2005, 146:2716-2725.
51. Lee J.N., Zhang X., Feramisco J.D., Gong Y., Ye J. Unsaturated fatty acids inhibit proteasomal degradation of Insig-1 at a postubiquitination step. J. Biol. Chem. 2008, 283:33772-33783.
52. Ka S.O., Kim K.A., Kwon K.B., Park J.W., Park B.H. Silibinin attenuates adipogenesis in 3T3-L1 preadipocytes through a potential upregulation of the insig pathway. Int. J. Mol. Med. 2009, 23:633-637.
53. Goldstein J.L., DeBose-Boyd R.A., Brown M.S. Protein sensors for membrane sterols. Cell 2006, 124:35-46.
54. Nogalska A., Sucajtys-Szulc E., Swierczynski J. Leptin decreases lipogenic enzyme gene expression through modification of SREBP-1c gene expression in white adipose tissue of aging rats. Metab. Clin. Exp. 2005, 54:1041-1047.
55. Jeon T.I., Esquejo R.M., Roqueta-Rivera M., Phelan P.E., Moon Y.A., Govindarajan S.S., Esau C.C., Osborne T.F. An SREBP-responsive microRNA operon contributes to a regulatory loop for intracellular lipid homeostasis. Cell Metab. 2013, 18:51-61.
56. Kim W., Kyung Lee E. Post-transcriptional regulation in metabolic diseases. RNA Biol. 2012, 9:772-780.
57. Hinman M.N., Lou H. Diverse molecular functions of Hu proteins. Cell. Mol. Life Sci. 2008, 65:3168-3181.
58. Poy M.N., Hausser J., Trajkovski M., Braun M., Collins S., Rorsman P., Zavolan M., Stoffel M. miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:5813-5818.
59. Fujiwara T., Mori Y., Chu D.L., Koyama Y., Miyata S., Tanaka H., Yachi K., Kubo T., Yoshikawa H., Tohyama M. CARM1 regulates proliferation of PC12 cells by methylating HuD. Mol. Cell. Biol. 2006, 26:2273-2285.
60. Pascale A., Amadio M., Scapagnini G., Lanni C., Racchi M., Provenzani A., Govoni S., Alkon D.L., Quattrone A. Neuronal ELAV proteins enhance mRNA stability by a PKCalpha-dependent pathway. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:12065-12070.
61. Sanna M.D., Quattrone A., Ghelardini C., Galeotti N. PKC-mediated HuD-GAP43 pathway activation in a mouse model of antiretroviral painful neuropathy. Pharmacol. Res. 2014, 81:44-53.
62. Lim C.S., Alkon D.L. PKCepsilon promotes HuD-mediated neprilysin mRNA stability and enhances neprilysin-induced Abeta degradation in brain neurons. PLoS One 2014, 9.